NCT03381703View on ClinicalTrials.gov

Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Constipation
Interventions
DRUG

YH12852

YH12852 administration

DRUG

14C-labeled YH12852

14C-labeled YH12852 administration

Trial Locations (1)

Unknown

Seoul National University Hospital Clinical Trial Center, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03381703 - Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852 | Biotech Hunter | Biotech Hunter